PCA3 Patient brochure

Patient brochure
Available in:

Find a PCA3 performing lab

Urine sample Locate a lab in your country to order your PCA3 collection tubes

User login

PCA3 Materials and News

Keyword


Systematic review confirms role of PCA3 to counsel in biopsy decisions and suggests that PCA3 may also assist in pre-treatment decision making Publication Read more
Analysis of REDUCE study shows that PCA3 can be used to predict repeat biopsy outcome in men treated with dutasteride Publication Read more
PCA3 Score for guiding decisions on the appropriateness of prostate biopsy and prostate cancer treatment Publication Read more
PCA3 Slide Resource Presentation Read more
The PCA3 Assay: indications for use in clinical practice Publication Read more
The PCA3 Assay; how is it used in clinical practice? A presentation of patient cases Presentation Read more
The PCA3 Score is not affected by chronic prostatitis Publication Read more
The performance of prostate cancer risk factors (including PCA3) to predict repeat biopsy outcome may be influenced by the number of previous repeat biopsies Publication Read more
Validation of PCA3 in placebo arm of REDUCE trial confirms that the PCA3 Assay can help guide repeat biopsy decisions Publication Read more
Study confirms that PCA3 is predictive of pathologically confirmed low-volume and insignificant prostate cancer Publication Read more
The PCA3 Assay improves the prediction of initial biopsy outcome and may be indicative of prostate cancer aggressiveness Publication Read more
French study shows that PCA3 is predictive of tumour volume and insignificant prostate cancer and may help in selecting prostate cancer patients for active surveillance Publication Read more
The PCA3 Score is associated with tumour volume and multifocality of prostate cancer Publication Read more
Japanese study confirms utility of PCA3 Assay in guiding prostate biopsy decisions in Asian men Publication Read more
Increased rate of dangerous bacterial infections after prostate biopsy leads to concern on overuse Web-publication Read more
The growing relevance of PCA3 in prostate cancer diagnosis Publication Read more
The Chun nomogram and the PCPT risk calculator, both incorporating PCA3, can aid in the decision to biopsy Publication Read more
The PCA3 Assay may help decide which patients with elevated PSA levels after photoselective vaporization of the prostate (PVP) need a prostate biopsy Publication Read more
The PCA3 Score is not affected by prostatitis Congress abstract Read more
PCA3 as a diagnostic marker for prostate cancer: a validation study on a Swedish population Publication Read more
Performance of the PCA3 Assay in pre-screened men with a PCA3 Score ≥ 100 Publication Read more
The PCA3 test shows improved performance characteristics and identification of significant prostate cancer compared to serum PSA as a first-line screening test Publication Read more
External validation of PCA3-based nomograms in a large European cohort of men at risk of prostate cancer demonstrates robustness, accuracy and applicability Publication Read more
Real-life practice UrOP study confirms role of PCA3 Assay as valid tool for prediction of biopsy outcome Publication Read more
Small, retrospective study confirms utility of PCA3 Assay to aid in guiding biopsy decisions in daily clinical practice Publication Read more
In men with a negative biopsy, an elevated PCA3 Score can predict prostate cancer at follow-up biopsy Publication Read more
PROGENSA™ PCA3 Assay can help predict outcome of initial prostate biopsies and may indicate prostate cancer aggressiveness Press release Read more
PCA3 for predicting short-term progression on biopsy in men with low-risk prostate cancer managed with active surveillance Publication Read more
The PCA3 Score is not affected by dutasteride; analysis of the REDUCE trial Congress abstract Read more
The REDUCE study shows that the PCA3 Assay can help guide repeat biopsy decisions, also in men treated with dutasteride Press release Read more
The PCA3 Score is independent of free/total PSA ratio and has a greater diagnostic accuracy than free/total PSA ratio for predicting repeat biopsy outcome Publication Read more
Small study suggests that PCA3 Score is not influenced by a recent prostate biopsy Letter to the editor Read more
Clinical use of the urine-based PCA3 Assay: increased specificity can aid in prostate cancer detection and risk assessment Web-publication Read more
A novel nomogram incorporating PCA3 can aid in biopsy decision making Press release Read more
PCA3 Assay; toward the age of reason? Publication Read more
Prostate cancer risk calculator now also includes PCA3 Score Website Read more
The PCA3 Assay is a feasible and very robust test in a community-based screening setting Congress abstract Read more
Combining the PCA3 Score with other clinical factors improves prediction of prostate biopsy outcome Congress abstract Read more
Combining PCA3 with PSA improves detection of prostate cancer Publication Read more
PCA3: a new biomarker ready for prime time Publication Read more
The PCA3 Assay: from laboratory to clinical practice Publication Read more
PCA3 is an independent significant predictor of pathologically confirmed insignificant prostate cancer Congress abstract Read more
PCA3 correlates with tumour volume and significance of cancer in men undergoing radical prostatectomy Congress abstract Read more
A nomogram incorporating PCA3 better identifies men at risk of harbouring prostate cancer who need a prostate biopsy Publication Read more
Prostate cancer diagnosis: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of PCA3 Publication Read more
PCA3 test: success story from laboratory to the market place Interview Read more
The PCA3 Assay performs well in clinical practice Publication Read more
PCA3 is the biomarker best capable of distinguishing prostate cancer from benign prostatic hyperplasia Publication Read more
The PCA3 Score predicts extracapsular extension and tumour volume in prostatectomy samples Publication Read more
The incorporation of PCA3 into a prostate cancer risk calculator improves diagnostic accuracy Publication Read more
Does PCA3 help identify clinically significant prostate cancer? Publication Read more
Molecular diagnostics of prostate cancer using PCA3 Publication Read more
Study shows prostate cancer gene 3 (PCA3) correlates with severity of prostate cancer Press release Read more
The PCA3 Score helps to decide who needs a repeat biopsy and may be indicative of clinical stage and significance of prostate cancer Publication Read more
PCA3: a molecular urine assay for predicting prostate biopsy outcome Publication Read more
New study backs use of gene-based urine test in prostate cancer Press release Read more
PCA3 Score correlates with tumour volume and grade in prostatectomy samples Publication Read more
A multiplex biomarker analysis of urine, including PCA3, for the early detection of prostate cancer Publication Read more
Progensa PCA3 test for prostate cancer detection Publication Read more
An evaluation of the PCA3 test: Pre-analytical effects, analytical performance, and diagnostic accuracy Publication Read more
Evaluation of the PCA3 Score to guide biopsy decision in Austrian patients Congress abstract Read more
Prostate biopsy: current status and limitations Publication Read more
Preliminary data suggest PROGENSA™ PCA3 Assay may be more specific than traditional testing methods Press release Read more
Promising data on molecular research test for prostate cancer published in peer-reviewed journal UROLOGY Press release Read more
International approvals: Gen-Probe PCA3 for diagnosis of prostate cancer in EU Press release Read more
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy Publication Read more
APTIMA PCA3 molecular urine test Publication Read more
Biological variation of PCA3 Score in men previously diagnosed with prostate cancer Congress abstract Read more
The PCA3 test in the diagnosis of prostate cancer Presentation Read more
The use of the PCA3 Assay when deciding on repeat biopsy; Patient case 1 from Dr. A. de la Taille Patient case Read more
The use of the PCA3 Assay when deciding on repeat biopsy; Patient case 2 from Prof. A. Stenzl Patient case Read more
The use of the PCA3 Assay when deciding on repeat biopsy; Patient case 3 from Prof. A. Stenzl Patient case Read more
The use of the PCA3 Assay when deciding on repeat biopsy; Patient case 4 from Prof. A. Stenzl Patient case Read more
The use of the PCA3 Assay when deciding on biopsy when there is a family history of prostate cancer; patient case 5 from Prof. B. Tombal Patient case Read more
The use of the PCA3 Assay when deciding on first biopsy; Patient case 6 from Dr. A. Stenzl Patient case Read more
The use of the PCA3 Assay when deciding on first biopsy; Patient case 7 from Dr. T. de Reijke Patient case Read more
The use of the PCA3 Assay when deciding on first biopsy; Patient case 8 from Dr. T. de Reijke Patient case Read more
The use of the PCA3 Assay when deciding on biopsy in a man with an elevated PSA level and a concomitant urinary condition; Patient case 12 from Prof. A. Stenzl Patient case Read more
The use of the PCA3 Assay when deciding on biopsy in a man with an elevated PSA level and a concomitant urinary condition; Patient case 9 from Dr. A. de la Taille Patient case Read more
The use of the PCA3 Assay when deciding on biopsy in a man with an elevated PSA level and a concomitant urinary condition; Patient case 10 from Prof. A. Stenzl Patient case Read more
The use of the PCA3 Assay when deciding on biopsy in a man with an elevated PSA level and a concomitant urinary condition; Patient case 11 from Dr. T. de Reijke Patient case Read more
The use of PCA3 Assay when deciding on therapy when prostate cancer has been detected. Patient case 13 from Prof. B. Tombal Patient case Read more
The use of PCA3 Assay when deciding on therapy when prostate cancer has been detected. Patient case 14 from Prof. B. Tombal Patient case Read more
Urinary markers for prostate cancer (Presentation in French) Presentation Read more
PCA3 patient cases Presentation Read more
What are currently the main problems in diagnosing prostate cancer? Interview with Prof. H. van Poppel Interview Read more
What is PCA3? Interview with Prof. J. Schalken Interview Read more
How was the PCA3 gene discovered? Interview with Prof. J. Schalken Interview Read more
What is the difference between PCA3 and DD3? Interview with Prof. J. Schalken Interview Read more
What are the most interesting features of the first gene-based marker for prostate cancer? Interview with Prof. H. van Poppel Interview Read more
What is the PCA3 test? Interview with Prof. J. Schalken Interview Read more
What is the PCA3 Score? Interview with Prof. J. Schalken Interview Read more
What does the PCA3 Score mean? Interview with Prof. J. Schalken Interview Read more
How would you explain the value of the PCA3 test for a patient? Interview with Prof. H. van Poppel Interview Read more
Where do you see the future value for the PCA3 test? Interview with Prof. B. Tombal Interview Read more
You recently performed a pilot study using PCA3 testing in an intention to biopsy population. What were the major findings of the study? Interview with Prof. B. Tombal Interview Read more

Get PCA3 patient info

PCA3 Patient brochure

Find a PCA3 performing lab

User login

PCA3 Materials and News